Рынок регенерации тканей в Северной Америке – тенденции отрасли и прогноз до 2029 года

Анализ и размер рынка

Регенерация тканей — это процесс повторного выращивания или замены поврежденной или больной ткани с целью ее восстановления или ремонта. Необходимость регенерации тканей обусловлена ​​наследственными нарушениями, деформациями и повреждением тканей, вызванным болезнями. Тканевая инженерия — это метод сохранения, восстановления и улучшения функции раненой ткани. Восстанавливая поврежденные органы, такие как почки, процесс регенерации тканей увеличивает продолжительность жизни пациента. Регенеративная медицина способна положить конец текущему дефициту донорских органов; например, кожа с реинжинирингом тканей чрезвычайно полезна для замены кожи, ожоговых ран и язв, которые поражают ногу и ступню.

Компания Data Bridge Market Research анализирует, что рынок регенерации тканей, который в 2021 году составил 12,98 млрд долларов США, к 2029 году вырастет до 38,35 млрд долларов США, и, как ожидается, его среднегодовой темп роста составит 14,5% в прогнозируемый период с 2022 по 2029 год. Отчет о рынке, подготовленный командой Data Bridge Market Research, включает в себя углубленный экспертный анализ, эпидемиологию пациентов, анализ линейки продуктов, анализ цен и нормативно-правовую базу.

Определение рынка

Процесс восстановления или замены поврежденной или больной ткани с целью ее восстановления или ремонта известен как регенерация тканей. Врожденные нарушения, аномалии и вызванные болезнью повреждения тканей увеличивают потребность в регенерации тканей. Тканевая инженерия — это метод сохранения, восстановления и улучшения функции поврежденной ткани. За счет восстановления поврежденных органов, таких как почки, процесс регенерации тканей увеличивает продолжительность жизни пациента.

Область отчета и сегментация рынка

Tissue Regeneration Market Dynamics

Drivers

• Increasing prevalence of chronic diseases and the need for surgeries

During the projected period, the market is expected to grow due to the increased use of biomarkers for illness detection and the rapid development of procedures such as stem cell technologies and gene therapy, among others. Increased responsiveness of the benefits and availability of equipment among doctors and convicts will also help to boost the tissue regeneration market's growth pace. The rising demand for tailored treatments will be a major market driver, boosting the demand for tissue regeneration even more. In addition, changing lifestyles and eating habits will increase the risk of chronic diseases, resulting in a faster market growth rate.

• Rising of the functions of 3D printing in tissue regeneration

 In the projected term, advancements in biomaterials, nanotechnology, cell treatments, and medication delivery are expected to boost the tissue regeneration market's growth. Government regulations, repayment concerns, particularly in emerging economies, and a lack of finance in developing countries are the factors most likely to stymie the tissue regeneration market's expansion. The market for tissue regeneration is expected to be hampered by rising organ transplantation costs and a scarcity of competent staff.

• Increase in popularity of tissue regeneration technology

The number of procedures for regeneration is on the rise. The use of tissue engineered vascular grafts in the treatment and surgery of cardiovascular disease is being researched at the pre-clinical stage. Progress is presently being made in the development of tissue engineered bladders outside of the patient's body and their successful transplantation.

Opportunities

During the forecast period, an increase in demand for tissue regeneration technologies such as 3D printing, as well as an increase in R&D activities, will present new opportunities for the tissue regeneration market. Furthermore, government grants and investments, as well as innovation in biomaterials, nanotechnology, cell treatments, and medication delivery, are likely to improve the market's positive potential in the future.

Restraints/Challenges

However, the North America market is likely to be hampered by tight government regulations, high treatment costs, and difficulty obtaining reimbursements and coverage for these therapies. This treatment is quite expensive (particularly for long-term options), may have negative effects on first-time patients, and may result in problems, infections, or ruptures in the early stages.

This tissue regeneration market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the tissue regeneration market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on Tissue Regeneration Market

The pandemic of COVID-19 has had a major impact on the health-care industry. Since the COVID 19 pandemic, clinical tissue engineering research has been made unavailable, and non-COVID 19 clinical trials have been reduced. Meanwhile, a number of pharmaceutical and biotech companies have redirected their focus to COVID-19 therapy medications and vaccines. Furthermore, the worldwide tissue engineering market has been constrained by a significant decline in cell and tissue donation programmes. As a result, delays and disturbances in clinical research, as well as cancellations or delays in tissue replacement and reconstructive treatments, stymie the North America tissue engineering market's growth.

 Recent Development

• In September 2019, Xeltis, a Swiss startup, has completed a USD 11.69 million Series D funding round to fund its valve and vascular research services. Established private and institutional investors, as well as all previous venture capitalists, contributed to the funding. Cardiovascular disease is the world's biggest cause of death. Through a therapy procedure known as ETR, Xeltis devices are designed to facilitate normal regeneration of the patient's blood vessels and hence cardiac function (Endogenous Tissue Restoration).

North America Tissue Regeneration Market Scope

The tissue regeneration market is segmented on the basis of component, raw material, application and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Components

• Cell Therapy
• Stem Cell Therapy
• Stem Cell Sources
• Existing and Development-stage Stem Cell Products
• Tissue Vascularization
• Cell Culturing
• Small Molecules and Biologics
• Others

Raw Material

• Synthetic
• Genetically Modified
• Biological

   Application

• Cardiovascular Disorders
• Oncology
• Dermatology
• Neurology
• Ophthalmology
• Others

End-User

• Hospitals
• Clinics
• Ambulatory Centers
• Laboratories

Tissue Regeneration Market Regional Analysis/Insights

The tissue regeneration market is analysed and market size insights and trends are provided by country, component, raw material, application and end user as referenced above.

The countries covered in the tissue regeneration market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of North America brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure growth Installed base and New Technology Penetration

The tissue regeneration market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for tissue regeneration market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the tissue regeneration market. The data is available for historic period 2010-2020.

Competitive Landscape and Tissue Regeneration Market Share Analysis

The tissue regeneration market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, North America presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to tissue regeneration market.

Some of the major players operating in the tissue regeneration market are:

• Arteriocyte Medical Systems Inc. (U.S.)
• Athersys Inc. (US)
• Cerapedics Inc. (U.S.)
• Co. Don AG (Germany)
• Cook Medical Inc. (США)
• US Stem Cell Inc. (США)
• Cytori Therapeutics, Inc. (США)
• Cerapedicsm, Inc. (США)
• Organogenesis, Inc. (США)
• Wright Medical Group NV (Нидерланды)
• Zimmer Biomet (США)
• ACell, Inc. (США)
• Tissue Regenix (США)

SKU-48023